Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Heron Therapeutics (HRTX)
NASDAQ:HRTX
Heron Therapeutics (HRTX) Stock Price & Analysis
1,450 Followers
HRTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.50 - $3.93
Previous Close$3.47
Volume7.51M
Average Volume (3M)2.25M
Market Cap
$522.77M
Enterprise Value$597.72M
Total Cash (Recent Filing)$80.41M
Total Debt (Recent Filing)$155.37M
Price to Earnings (P/E)―
Beta2.41
Next Earnings
Aug 05, 2024EPS Estimate
-$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding150,653,158
10 Day Avg. Volume1,878,688
30 Day Avg. Volume2,247,612
Standard Deviation0.26
R-Squared0.13
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-14.32
Price to Sales (P/S)3.83
Price to Cash Flow (P/CF)49.60
P/FCF Ratio20.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.70
Enterprise Value/Gross Profit9.65
Enterprise Value/Ebitda-5.73
Forecast
1Y Price Target
$6.75Price Target Upside146.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Heron Therapeutics News
PremiumCompany Announcements
Heron Therapeutics’ ZYNRELEF Review Date Set by FDA
PremiumCompany Announcements
Heron Therapeutics Submits ZYNRELEF® Supplement to FDA
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
HRTX FAQ
What was Heron Therapeutics’s price range in the past 12 months?
Heron Therapeutics lowest stock price was $0.50 and its highest was $3.93 in the past 12 months.
What is Heron Therapeutics’s market cap?
Currently, no data Available
When is Heron Therapeutics’s upcoming earnings report date?
Heron Therapeutics’s upcoming earnings report date is Aug 05, 2024 which is in 34 days.
How were Heron Therapeutics’s earnings last quarter?
Heron Therapeutics released its earnings results on May 07, 2024. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.075 by $0.055.
Is Heron Therapeutics overvalued?
According to Wall Street analysts Heron Therapeutics’s price is currently Undervalued.
Does Heron Therapeutics pay dividends?
Heron Therapeutics does not currently pay dividends.
What is Heron Therapeutics’s EPS estimate?
Heron Therapeutics’s EPS estimate is -$0.04.
How many shares outstanding does Heron Therapeutics have?
Heron Therapeutics has 150,653,150 shares outstanding.
What happened to Heron Therapeutics’s price movement after its last earnings report?
Heron Therapeutics reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.075. Following the earnings report the stock price went up 1.056%.
Which hedge fund is a major shareholder of Heron Therapeutics?
Among the largest hedge funds holding Heron Therapeutics’s share is Fortitude Family Office, LLC. It holds Heron Therapeutics’s shares valued at 778.
---
Heron Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.75 (146.35% Upside)
$6.75 (146.35% Upside)
Blogger Sentiment
Bullish
HRTX Sentiment 80%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Negative
Last 7 Days ▼ 1.7%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
199.13%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.35%
Trailing 12-Months
Company Description
Heron Therapeutics
Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bio erodible, injectable and implantable delivery systems. Heron Therapeutics was founded in February 1983 and is headquartered in Redwood City, CA.
---
HRTX Company Deck
---
HRTX Earnings Call
Q1 2024
0:00 / 0:00
---
HRTX Stock 12 Month Forecast
Average Price Target
$6.75
▲(146.35% Upside)
Technical Analysis
Best Analysts Covering HRTX
1 Year
1 Year Success Rate
10/33 ratings generated profit
1 Year Average Return
-13.06%
reiterated a buy rating 2 months ago
Copying Serge Belanger's trades and holding each position for 1 Year would result in 30.30% of your transactions generating a profit, with an average return of -13.06% per trade.
---